The Health and Human Services Office of Inspector General finds woeful mismanagement by the department of the contracts and work to build the federal health insurance exchange.
Allow drug spending growth has slowed, it is still a significant category of cost and adding drug benefits to Medicare and Medicaid has caused concern about how those drugs are paid for. A report to the Centers for Medicare and Medicaid Services discusses new methods for reimbursing for drugs.
The Congressional Budget Office releases a presentation on how it calculates long-term projections fro Medicare and Medicaid spending. More than a little frightening, and the absence of serious bipartisan discussion about reducing this spending is disturbing in its economic implications.